NEW YORK (GenomeWeb News) – Helicos BioSciences has appointed Steve Lombardi, president and COO of the company, to take over the role of CEO for Stan Lapidus, who will remain chairman of the board of directors. Lombardi will retain his position as president of the company. He has served as VP of Applied Biosystems’ DNA sequencing and genetic analysis unit, and he has been a senior VP at Affymetrix.
Chromatide has named Nigel Slater, Brian Adger, and Eric Atherton to its scientific advisory board. Adger has over 30 years experience in the pharmaceutical and biotechnology industries, Atherton has spent three decades in peptide chemistry, and Slater of Cambridge University has spent 25 years in bioproduct manufacturing, industrial, and academic laboratories.
Mario Ehlers has resigned from his spot as chief medical officer at Pacific Biometrics, a job he has held since 2002. The company said he plans to take a job in academia, and that he has signed a six-month consulting agreement with the company.
Oxford Nanopore has named its technical advisory board, which includes professor Hagan Bayley of the University of Oxford; Dan Branton and Jene Golovchenko of Harvard University; David Deamer and Mark Akeson of the University of California, Santa Cruz; Amit Meller of Boston University.
The University of Delaware has appointed the Delaware Biotechnology Institute’s associate director, Karl Steiner, to be senior vice provost for research and strategic initiatives. Steiner will lead the research office, and will develop collaborative partnerships and generate competitive proposals to federal funding agencies, among other duties. Steiner has been at the University since 1984, and he has worked at programs funded by the National Institutes of Health, the National Science Foundation, the Department of Defense, the Department of Energy, the State of Delaware, foundations and the private sector.
Proteros Biostructures has named Gerhard Muller chief scientific officer and managing director of its subsidiary, Proteros Fragments. Muller formerly was VP of drug discovery at GPC Biotech, and he has worked at Glaxo, Bayer, and NV Organon.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.